Events & Presentations
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
August 2nd -5th, Four Seasons Resort, Napa Valley, California
Breakout Session hosted by: Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX, Inc., Perseus SENOLYTIX, Inc. and Ponce Aurora, Inc. (limited attendance available)
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
October 21st to 23rd, Berlin
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
June 5th, 2026 - Royal Sonesta New Orleans
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
May 14th-17th 2026 - Lighthaven, Berkeley CA
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
March 10-12, 2026 - Washington D.C.
Kevin Slawin, M.D., Founder and CEO Eos SENOLYTIX
October 23rd, 2025, NYC
Longevity Investors
September 22nd - 25th, 2025 - Le Grande Bellevue, Gstaad, Switzerland
Presenter: Kevin Slawin, M.D., Founder and CEO, Eos SENOLYTIX
September 16 - 19, 2025, Rome, Italy
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
May 20 2025, 15:30 – 17:30 | Biomed Israel 2025
Novel Gerotherapeutic Peptide PTC-2105 Demonstrates Features of a Safe and Effective Gerotherapeutic in Aged Mice
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
March 14, 2025 | Toulouse, FR
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
March 12th, 2025
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
February 27-28, 2025
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
14 November 2024 | 12:30 PM GMT/7:30 AM EST| Online
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
June 10-11, 2024 | London, England
© 2026 Eos SENOLYTIX - Investor Relations.